Ghazal Tansir | Oncology | Best Researcher Award

Published on by Global Academic Awards

Dr. Ghazal Tansir | Oncology | Best Researcher Award

All India Institute Of Medical Sciences Delhi | India

Dr. Ghazal Tansir, is an accomplished medical oncologist and researcher with a distinguished academic and clinical trajectory, holding an MBBS from Vardhman Mahavir Medical College, an MD in Internal Medicine from PGIMER, and a DM in Medical Oncology from AIIMS, New Delhi. She has served as Senior Resident and Research Consultant at AIIMS and is currently Assistant Professor at CAPFIMS-AIIMS, New Delhi. Dr. Tansir is an active member of the American Society of Clinical Oncology, European Society of Medical Oncology, and Indian Society of Medical and Pediatric Oncology. She has received multiple honors, including gold medals in Community Medicine and Ophthalmology, the AK Gadpayle Gold Medal in MD, selection for the ACORD protocol development workshop, the ASCO Merit Award, the ESMO Travel Grant, and the IDEA Award by Conquer Cancer. Her research contributions encompass over fifteen publications, focusing on rare cancers, sarcomas, and translational oncology, with studies on synovial sarcoma, mesenchymal chondrosarcoma, desmoid tumors, Li Fraumeni syndrome, and young-onset lung cancer. Dr. Ghazal Tansir has presented her work extensively at international conferences, including ASCO, ESMO, and the Connective Tissue Oncology Society, earning recognition for clinical and translational research excellence, making her a highly impactful researcher in medical oncology.

Profile: Google Scholar

Featured Publications

Tansir, G., Gupta, C., Mehta, S., Kumar, P., Soneja, M., & Biswas, A. (2017). Expanded dengue syndrome in secondary dengue infection: A case of biopsy proven rhabdomyolysis induced acute kidney injury with intracranial and intraorbital bleeds. Intractable & Rare Diseases Research, 6(4), 314–318.

Kumar, P., Tansir, G., Sasmal, G., Dixit, J., & Sahoo, R. (2016). Left pulmonary agenesis with right lung bronchiectasis in an adult. Journal of Clinical and Diagnostic Research: JCDR, 10(9), OD15.

Tansir, G., Kumar, P., Pius, A., Sunny, S. K., & Soneja, M. (2019). Pseudo-pseudo Meigs’ syndrome: A rare presentation of systemic lupus erythematosus. Reumatismo, 71(2), 108–112.

Biswas, S., Kumar, P., Tansir, G., & Biswas, A. (2019). Case report: Cardiac tamponade in dengue hemorrhagic fever: An unusual manifestation of a common disease. The American Journal of Tropical Medicine and Hygiene, 101(2), 448.

Tansir, G., Rastogi, N., Ramteke, P., Kumar, P., Soneja, M., Biswas, A., Kumar, S., & Jorwal, P. (2017). Disseminated mucormycosis: A sinister cause of neutropenic fever syndrome. Intractable & Rare Diseases Research, 6(4), 310–313.

Cheng Yi | Oncology | Best Researcher Award

Published on by Global Academic Awards

Mr. Cheng Yi | Oncology | Best Researcher Award

West China Hospital of Sichuan University | China

Mr. Cheng Yi, a distinguished Medical Doctor from Sichuan, currently serves as a professor and doctoral supervisor at the Cancer Center of West China Hospital, Sichuan University, and as an adjunct doctoral supervisor at Chengdu University of Traditional Chinese Medicine. He earned his Bachelor and Master of Medicine from Xi’an Jiaotong University, his Doctor of Medicine from Fudan University, and completed postdoctoral research at the University of Toronto. Since 1996, he has been deeply engaged in oncology clinical practice, scientific research, and teaching, advancing to professor and chief physician in 2006. His academic roles include standing committee and deputy director positions across multiple Chinese medical associations, reflecting his leadership in oncology and integrative medicine. With 138 publications, over 2,422 citations, and an h-index of 26, his research spans nanomedicine, cancer therapeutics, molecular oncology, immunotherapy, and systematic reviews, with impactful studies published in Journal of Materials Chemistry B, Nano Research, Frontiers in Oncology, PLoS One, and Journal of Cancer Research and Clinical Oncology. His international experience and consistent contributions to cancer treatment innovation highlight his strong candidacy for the Best Researcher Award, showcasing excellence in scientific impact, academic mentorship, and translational oncology research.

Profile: Scopus | Orcid

Featured Publications

Zhang, L.-N., Wei, Y.-F., Ran, X.-Y., Shi, L., Wang, Z.-Y., Chen, S.-Y., Yi, C., Yu, X.-Q., & Li, K. (2025). Liberating exciton transfer as a pioneering strategy to construct type I photosensitizers for hypoxia deep-seated metastases suppression. JACS Au. Advance online publication.

Tan, S., Feng, M., Zhou, N., Zhang, S., Yi, C., & Gou, H. (2025). DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer. Cancer. Advance online publication.

Chen, P., Hou, W., Li, C., Liang, Q., Ma, L., Zhao, X., & Yi, C. (2025). Lived experiences of patients with advanced pancreatic cancer on patient-reported outcomes (PROs) management: A qualitative phenomenological study in Southwest China. BMJ Open, 15(1), e084259.

Ran, X.-Y., Xia, W.-L., Zhang, L.-N., Yu, X.-Q., Chen, P., Xie, K.-P., Zhao, Y., Yi, C., & Li, K. (2024). De novo design of type-I photosensitizer agents based on structure-inherent low triplet energy for hypoxia photodynamic therapy. Materials Horizons. Advance online publication.

Tan, S., Zhang, S., Zhou, N., Cai, X., Yi, C., & Gou, H. (2023). Efficacy and safety of fruquintinib dose-escalation strategy for elderly patients with refractory metastatic colorectal cancer: A single-arm, multicenter, phase II study. Cancer Medicine, 13(1), e6786.

Wei, Y., Zheng, L., Yang, X., Luo, Y., Yi, C., & Gou, H. (2023). Identification of immune subtypes and candidate mRNA vaccine antigens in small cell lung cancer. The Oncologist, 28(11), oyad193.

Maryam Azizi | food packaging | Best Researcher Award

Published on by Global Academic Awards

Assoc Prof Dr. Maryam Azizi | food packaging | Best Researcher Award

Assoc Prof Dr. Maryam Azizi, Iran

Dr. Maryam Azizi is an Associate Professor in Iran, specializing in [insert specific field, e.g., molecular biology, nanotechnology, etc.]. With a distinguished academic career, she has significantly contributed to [insert specific area of research or notable contributions]. Dr. Azizi holds a Ph.D. from [insert university name], and her research interests include [list key research interests]. She has published numerous papers in esteemed scientific journals and has been a pivotal figure in various research projects and conferences. Dr. Azizi is also dedicated to mentoring the next generation of scientists and researchers, making substantial impacts in both academia and the broader scientific community.

Publication profile

🎓 Education :

Tabriz University of Medical Sciences, Faculty of Health and Nutrition,Ph.D. in Food Science and Technology,2017-2021
Supervisors: Dr. Ali Ehsani and Dr. Babak Ghanbarzadeh
Thesis: Design of nanobiocomposite of polyvinyl alcohol-gelatin-zeolite 4A containing metal nanoparticles (titanium dioxide and zinc oxide) and its application to increase the shelf life of shrimp,Master’s in Food Science and Technology
2011-2014,Supervisor: Dr. Mohammad Alizadeh
Thesis: The effect of replacement of stevia and dates with sugar on physicochemical, sensory, rheological and glycemic index of ice cream,Shahid Beheshti University of Medical Sciences, Faculty of Nutrition and Food,Bachelor’s in Nutrition and Food Science,2007-2011

 Experience:

Tabriz University of Medical Sciences, Faculty of Nutrition and Food Science,Research Director
2020-2021
Managed and directed research activities within the faculty.,Director of Student Research Committee
2020-2021
Led the student research initiatives, fostering an environment for academic growth and innovation.,Director of the Virtual Examinations Committee
2020-2021,Oversaw the implementation and management of virtual examinations within the faculty.,Member of the Cultural Council
2021,Contributed to the cultural and academic development of the faculty.

Key Areas of Research Expertise:

  • Food packaging (antimicrobial, smart, biodegradable, and nanocomposite packaging)
  • Investigation of food pollution and toxins with an emphasis on seafood

Awards:

Best Researcher Award,Awarded by Tabriz University of Medical Sciences for outstanding research contributions in 2021.,Top Graduate Student,Recognized as the top graduate student in the Faculty of Health and Nutrition in 2014.,Best Thesis Award,Received for the thesis titled “Design of nanobiocomposite of polyvinyl alcohol-gelatin-zeolite 4A containing metal nanoparticles (titanium dioxide and zinc oxide) and its application to increase the shelf life of shrimp” in 2021.

Publication Top Notes

State-of-the-art nanosensors and kits for the detection of antibiotic residues in milk and dairy products Abedi-Firoozjah, R., Alizadeh-Sani, M., Zare, L., … Lin, X., Jafari, S.M.

Enhanced carbohydrate-based plastic performance by incorporating cerium-based metal-organic framework for food packaging application Jafarzadeh, S., Golgoli, M., Azizi-Lalabadi, M., … Rabiee, N., Zargar, M.
Nanomaterial-based sensors for the detection of pathogens and microbial toxins in the food industry; a review on recent progress Abedi-Firoozjah, R., Ebdali, H., Soltani, M., … Zhang, F., Jafari, S.M
Starch-gelatin blend films: A promising approach for high-performance degradable food packaging Zhang, W., Azizi-Lalabadi, M., Jafarzadeh, S., Jafari, S.M.
Maillard-reaction (glycation) of biopolymeric packaging films; principles, mechanisms, food applications Zhang, W., Azizi-Lalabadi, M., Roy, S., … Castro-Muñoz, R., Jafari, S.M.

Fatemeh Moradian | Cancer Award | Best Researcher Award

Published on by Global Academic Awards

Assoc Prof Dr. Fatemeh Moradian | Cancer Award | Best Researcher Award

Assoc Prof Dr. Fatemeh Moradian,Sari Agricultural Sciences and Natural Resources University, Iran

Dr. Fatemeh Moradian is an Associate Professor with a PhD in Biochemistry, specializing in enzymes and cancer mechanisms. She taught at Sari Agricultural Sciences and Natural Resources University for 13 years. Her research spans diverse conferences globally, focusing on biochemistry, microbiology, and biotechnology. Dr. Moradian’s extensive publications include studies on proteases, enzymes, and their applications in health and agriculture. She has conducted sabbatical research at the University of Alberta, Canada. Her work on lactoferrin and its antimicrobial and anticancer effects highlights her contributions to biomedical sciences. 🧬🔬

 

Publication profile

🎓 Education and Academic Background

Fatemeh (Elham) Moradian holds a PhD in Biochemistry and is an Associate Professor, having earned her Bachelor’s degree in Biology from the University of Shiraz in 1996, followed by a Master’s and PhD in Biochemistry from the University of Tarbiat Modares in 2000 and 2006, respectively.

📚 Teaching Experience

She has enriched the academic community through her expertise in Biochemistry, Enzymology, Biochemical Mechanisms of Cancer, Animal Cell Culture, and Bioinformatics. Her teaching tenure spans from 2006 to 2019 at Sari Agricultural Sciences and Natural Resources University.

Research Focus

Based on the cited research publications, F. Moradian’s research focus primarily revolves around enzymology, biotechnology, and environmental applications. Moradian has contributed significantly to the isolation, purification, and characterization of enzymes such as α-amylase and protease from Bacillus species, highlighting their stability and applications in various industrial sectors. Additionally, their work extends to environmental sciences, particularly in the treatment of landfill leachate using advanced oxidation processes. Moradian has also explored the biomedical aspects of proteins like lactoferrin, emphasizing its antimicrobial and anticancer properties. Overall, Moradian’s research spans enzyme technology, bioprocessing, environmental remediation, and bioactive molecule applications. 🧪🌱

 

Publication Top Notes

Ken Kato | Oncology Award | Excellence in Research

Published on by Global Academic Awards

Dr. Ken Kato | Oncology Award | Excellence in Research

Dr. Ken Kato, National Cancer Center Hospital, Japan

Dr. Ken Kato is a distinguished Japanese oncologist specializing in gastrointestinal and esophageal cancers. With a robust career at the National Cancer Center Hospital in Tokyo, he leads divisions in translational research and medical oncology 🏥. Holding both an M.D. and a Ph.D. from prestigious institutions 🎓, Dr. Kato has a notable presence in clinical and research domains, with expertise in molecular targets and immunotherapy for cancer 🧬. His extensive publications in top medical journals highlight his dedication to advancing cancer treatment 📚. Dr. Kato is also an active member of several professional societies worldwide 🌏.

Publication profile

Scopus

Education

Dr. Kato earned his Ph.D. from Kyushu University in 2001 and his M.D. in 1995. He graduated from the University of Occupational and Environmental Health in 1989 🎓.

Research Focus

Dr. Ken Kato is a leading researcher in gastrointestinal and esophageal cancers, focusing primarily on early detection, treatment, and the molecular mechanisms of these malignancies 🧬. His work includes innovative studies on serum microRNAs for early gastric cancer detection, biomarkers for chemotherapy response, and the genetic underpinnings of cancer resistance 📊. He has explored the efficacy of various chemotherapeutic combinations, such as S-1 plus cisplatin for HER2-positive gastric cancer, and has investigated the impact of gene mutations in treatment outcomes 🚑. Dr. Kato’s research aims to advance precision medicine in oncology, improving patient survival and treatment efficacy 🌟.

Publication Top Notes

  • A novel combination of serum microRNAs for the detection of early gastric cancer – Abe, S., Matsuzaki, J., Sudo, K., … Saito, Y., Ochiya, T. Gastroenterological Endoscopy, 2021, 63(6), pp. 1310 📅, Cited by: 0 🔍
  • ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy – Takahashi, T., Yamahsita, S., Matsuda, Y., … Nagino, M., Ushijima, T. Journal of Cancer Research and Clinical Oncology, 2015, 141(3), pp. 453–463 📅, Cited by: 21 📊
  • Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer – Honma, Y., Shimada, Y., Takashima, A., … Sekine, S., Kushima, R. International Journal of Clinical Oncology, 2014, 19(5), pp. 863–870 📅, Cited by: 3 📈
  • Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer – Takahashi, N., Yamada, Y., Taniguchi, H., … Hamaguchi, T., Shimada, Y. BMC Research Notes, 2014, 7(1), 271 📅, Cited by: 41 🔬
  • Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection – Shoji, H., Yamada, Y., Taniguchi, H., … Hamaguchi, T., Shimada, Y. Cancer Science, 2014, 105(8), pp. 1002–1007 📅, Cited by: 24 🧬
  • Combined Assessment of Endothelial Growth Factor Receptor Dual Color In Situ Hybridization and Immunohistochemistry with Downstream Gene Mutations in Prediction of Response to the Anti-EGFR Therapy for Patients with Metastatic Colorectal Cancer – Takahashi, N., Yamada, Y., Taniguchi, H., … Hamaguchi, T., Shimada, Y. Archives of Medical Research, 2014, 45(5), pp. 366–374 📅, Cited by: 7 🔍
  • A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI) – Kato, K., Muro, K., Ando, N., … Nagai, K., Kato, H. Esophagus, 2014, 11(3), pp. 183–188 📅, Cited by: 30 🩺
  • Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: Combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912 – Takashima, A., Boku, N., Kato, K., … Shimada, Y., Ohtsu, A. Gastric Cancer, 2014, 17(3), pp. 522–528 📅, Cited by: 26 📊
  • Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma – Hayashi, H., Arao, T., Matsumoto, K., … Nishio, K., Yamada, Y. Oncotarget, 2014, 5(9), pp. 2588–2595 📅, Cited by: 33 🧪
  • Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer – Makazu, M., Kato, K., Takisawa, H., … Yamada, Y., Shimada, Y. Diseases of the Esophagus, 2014, 27(1), pp. 42–49 📅, Cited by: 31 🩹